167 related articles for article (PubMed ID: 36549661)
1. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis.
Massicotte-Azarniouch D; Detwiler RK; Hu Y; Falk RJ; Saha MK; Hogan SL; Derebail VK
Nephrol Dial Transplant; 2023 Aug; 38(9):2009-2018. PubMed ID: 36549661
[TBL] [Abstract][Full Text] [Related]
2. Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
Massicotte-Azarniouch D; Detwiler RK; Hu Y; Falk RJ; Saha MK; van Duin D; Hogan SL; Derebail VK
Am J Kidney Dis; 2023 Dec; ():. PubMed ID: 38160700
[TBL] [Abstract][Full Text] [Related]
3. Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease.
Jorgenson MR; Descourouez JL; Singh T; Astor BC; Panzer SE
Pharmacotherapy; 2018 Jan; 38(1):51-57. PubMed ID: 29136299
[TBL] [Abstract][Full Text] [Related]
4. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
5. Belatacept for kidney transplant recipients.
Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
[TBL] [Abstract][Full Text] [Related]
7. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
8. Outcome of kidney transplantation in pediatric patients with ANCA-associated glomerulonephritis: a single-center experience.
Noone D; Yeung RSM; Hebert D
Pediatr Nephrol; 2017 Dec; 32(12):2343-2350. PubMed ID: 28766066
[TBL] [Abstract][Full Text] [Related]
9. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
[No Abstract] [Full Text] [Related]
10. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients.
Kang W; Sampaio MS; Huang E; Bunnapradist S
Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.
Sprangers B; Riella LV; Dierickx D
Am J Kidney Dis; 2021 Aug; 78(2):272-281. PubMed ID: 33774079
[TBL] [Abstract][Full Text] [Related]
12. Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.
Taylor E; Jones M; Hourigan MJ; Johnson DW; Gill DS; Isbel N; Hawley CM; Marlton P; Gandhi MK; Campbell SB; Mollee P
Nephrol Dial Transplant; 2015 Oct; 30(10):1774-9. PubMed ID: 26188340
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients.
Liu M; Husain S; Famure O; Li Y; Kim SJ
Prog Transplant; 2019 Jun; 29(2):185-193. PubMed ID: 30845885
[TBL] [Abstract][Full Text] [Related]
14. The incidence of post-transplant malignancies in kidney transplant recipients treated with Rituximab.
Bachelet T; Visentin J; Davis P; Taton B; Guidicelli G; Kaminski H; Merville P; Couzi L
Clin Transplant; 2021 Feb; 35(2):e14171. PubMed ID: 33247459
[TBL] [Abstract][Full Text] [Related]
15. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression.
Caillard S; Dharnidharka V; Agodoa L; Bohen E; Abbott K
Transplantation; 2005 Nov; 80(9):1233-43. PubMed ID: 16314791
[TBL] [Abstract][Full Text] [Related]
16. Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients.
Zierhut H; Kanzelmeyer N; Buescher A; Höcker B; Mauz-Körholz C; Tönshoff B; Metzler M; Pohl M; Pape L; Maecker-Kolhoff B
Pediatr Transplant; 2021 Sep; 25(6):e14042. PubMed ID: 34021949
[TBL] [Abstract][Full Text] [Related]
17. A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.
Caillard S; Cellot E; Dantal J; Thaunat O; Provot F; Janbon B; Buchler M; Anglicheau D; Merville P; Lang P; Frimat L; Colosio C; Alamartine E; Kamar N; Heng AE; Durrbach A; Moal V; Rivalan J; Etienne I; Peraldi MN; Moreau A; Moulin B;
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1663-1670. PubMed ID: 28818847
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort.
Huang JG; Tan MYQ; Quak SH; Aw MM
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29071779
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause.
Lim WH; Wong G; McDonald SP; Chakera A; Luxton G; Isbel NM; Pilmore HL; Barbour T; Hughes P; Chadban SJ
Sci Rep; 2018 Jun; 8(1):9021. PubMed ID: 29899355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]